Zhang Xiaodong, Cai Jun, Klueber Kathleen M, Guo Zhanfang, Lu Chengliang, Qiu Mengsheng, Roisen Fred J
Department of Anatomical Sciences and Neurobiology, University of Louisville, School of Medicine, Louisville, Kentucky 40202, USA.
Stem Cells. 2005 Mar;23(3):442-53. doi: 10.1634/stemcells.2004-0274.
Neurosphere-forming cell (NSFC) lines have been derived from cultures of adult olfactory neuroepithelium obtained from patients and cadavers. These progenitors remain undifferentiated when maintained in minimal essential medium with 10% fetal bovine serum, but have the potential to differentiate along glial or neuronal lineages. However, few of these cells ever express mature neuronal or glial markers in defined medium. To evaluate the potential of NSFCs to form oligodendrocytes, two transcription factors, Olig2 and Nkx2.2, were introduced into NSFCs to determine whether their expression is sufficient for oligodendrocyte differentiation, as has been shown in the embryonic avian and murine central nervous systems in vivo. NSFCs transfected with Olig2 or Nkx2.2 alone exhibited no phenotypic lineage restriction. In contrast, simultaneous transfection of Olig2 and Nkx2.2 cDNA produced characteristic oligodendrocyte morphology and antigenicity, including myelin basic protein (MBP). Furthermore, a population of Olig2-expressing NSFCs also expressed Sox10. Cotransfection of NSFCs with Nkx2.2 and Sox10, but not Olig2 and Sox10, produced a MBP(+) oligodendrocytic phenotype. Coculture of NSFCs transfected with Olig2 and Nkx2.2 or Nkx2.2 and Sox10 with purified sensory neurons, demonstrated frequent contacts between NSFC processes and axons, including the early stages of ensheathment. These studies demonstrate transcription factors governing early development of chick and mouse oligodendrocyte formation, also apply to human progenitors isolated from adult olfactory neuroepithelium. Our long-term goal is to develop cell populations for future studies used to determine the therapeutic utility of these olfactory-derived NSFCs for autologous transplantation into donors with central nervous system trauma or neurodegenerative diseases.
神经球形成细胞(NSFC)系源自从患者和尸体获取的成人嗅神经上皮培养物。当在含有10%胎牛血清的最低必需培养基中培养时,这些祖细胞保持未分化状态,但有沿神经胶质或神经元谱系分化的潜力。然而,这些细胞中很少有在限定培养基中表达成熟神经元或神经胶质标志物的。为了评估NSFC形成少突胶质细胞的潜力,将两种转录因子Olig2和Nkx2.2导入NSFC,以确定它们的表达是否足以促进少突胶质细胞分化,正如在胚胎期禽类和鼠类中枢神经系统体内所显示的那样。单独用Olig2或Nkx2.2转染的NSFC没有表现出表型谱系限制。相比之下,同时转染Olig2和Nkx2.2 cDNA产生了特征性的少突胶质细胞形态和抗原性,包括髓鞘碱性蛋白(MBP)。此外,一群表达Olig2的NSFC也表达Sox10。NSFC与Nkx2.2和Sox10共转染,而不是与Olig2和Sox10共转染,产生了MBP(+)少突胶质细胞表型。将用Olig2和Nkx2.2或Nkx2.2和Sox10转染的NSFC与纯化的感觉神经元共培养,显示NSFC突起与轴突之间频繁接触,包括包裹的早期阶段。这些研究表明,控制鸡和小鼠少突胶质细胞形成早期发育的转录因子,也适用于从成人嗅神经上皮分离的人类祖细胞。我们的长期目标是培养细胞群体,用于未来的研究,以确定这些源自嗅觉的NSFC用于自体移植到患有中枢神经系统创伤或神经退行性疾病的供体的治疗效用。